NeuroMetrix Just Filed Its Annual Report: Net Loss per Common ...

Net Loss per Common Share

Basic and dilutive net loss per common share were as follows:
< td style="width:0.1%"/>
Years Ended December 31,
Net loss applicable to common stockholders$(4,416,609)$(2,281,457)
Weighted average number of common shares outstanding, basic and dilutive7,130,139 5,111,045 
Net loss per common share applicable to common stockholders, basic and diluted$(0.62)$(0.45)
The following potentially dilutive weighted average number of common stock equivalents were excluded from the calculation of diluted net loss per common share because their effect was anti-dilutive for each of the periods presented:
Years Ended December 31,
Options525,462 504,045 
Unvested restricted stock awards96,250 30,000 
Unvested restricted stock units194,731 — 
Convertible preferred stock62 62 
Total816,505 534,107 

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever NeuroMetrix makes a similar move, sign up!

Auto Refresh